Table 1.
Baseline characteristics of randomized participants 1.
| Low Avocado Allotment (n = 37) | High Avocado Allotment (n = 35) | |
|---|---|---|
| Characteristic | ||
| Age, years | 46.5 ± 11.3 | 44.5 ± 8.4 |
| Female, % | 97.3 | 100 |
| Years lived in the United States | 16.5 ± 12.6 | 17.7 ± 12.9 |
| Country of birth, % | ||
| Mexico | 86.5 | 80.0 |
| United States or Other | 13.5 | 20.0 |
| Heritage, % | ||
| Central America | 2.7 | 2.9 |
| Mexico | 97.3 | 97.1 |
| Marital status, % | ||
| Married or cohabitation | 73.0 | 71.5 |
| Separated, divorced, or widowed | 18.9 | 20.1 |
| Single | 8.1 | 8.6 |
| Highest level of education achieved, % | ||
| High school | 24.3 | 28.6 |
| Trade school or Associate’s degree | 23.6 | 31.4 |
| Bachelor’s degree | 18.2 | 17.1 |
| Master’s degree or above | 2.7 | 5.8 |
| No diploma | 10.8 | 8.6 |
| Other | 18.2 | 8.6 |
| Employment status, % | ||
| Employed for wages | 24.3 | 28.6 |
| Self-employed | 10.8 | 8.6 |
| Homemaker | 48.7 | 40.0 |
| Other | 16.2 | 22.9 |
| Total family income in US dollars/year, % | ||
| Less than $30,000 | 40.5 | 54.3 |
| Greater than $30,000 | 40.5 | 37.1 |
| Unknow | 18.9 | 8.6 |
| Moderate vigorous physical activity, minutes/week | 593.9 ± 672.9 | 582.9 ± 649.8 |
| BMI, kg/m-squared | 30.6 ± 6.1 | 30.5 ± 6.2 |
| Waist circumference, cm | 93.2 ± 13.4 | 95.0 ± 12.7 |
| Systolic blood pressure, mmHg | 116.9 ± 15.8 | 111.5 ± 15.7 |
| Diastolic blood pressure, mmHg | 73.4 ± 12.3 | 69.4 ± 8.8 |
| Diabetes/prediabetes status 2, % | 54.2 | 45.8 |
| Glucose, mg/dL | 102.3 ± 38.3 | 103.5 ± 30.4 |
| Hemoglobin A1c% | 5.9 ± 1.2 | 5.7 ± 1.0 |
| hsCRP, mg/L | 3.9 ± 4.5 | 2.9 ± 2.8 |
| GGT, IU/L | 25.1 ± 33.0 | 21.9 ± 15.0 |
| AST, IU/L | 21.0 ± 10.3 | 21.8 ± 12.0 |
| ALT, IU/L | 25.5 ± 21.8 | 23.3 ± 18.3 |
| Alkaline phosphatase, IU/L | 76.2 ± 21.8 | 71.3 ± 19.1 |
| NAFLD fibrosis score 3 | −2.2 ± 1.2 | −2.1 ± 1.4 |
1 Mean ± SD (all such values). 2 Defined as a fasting glucose level ≥ 100 mg/dL or glycosylated hemoglobin ≥ 5.7% and/or reported use of glucose-lowering medication, at baseline. 3 <−1.455: predictor of absence of significant fibrosis (F0–F2 fibrosis), −1.455 to 0.676: indeterminate score, >0.676: predictor of presence of significant fibrosis (F3-F4 fibrosis). ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; BMI, body mass index; GGT, gamma-glutamyl transferase; hsCRP, high-sensitivity c-reactive protein; NAFLD, Non-alcoholic fatty liver disease; US, United States.